Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Safety and Efficacy of the UNILEXA Exoskeleton for Regular Verticalization and Assisted Walking

NCT06782113 is registered in ClinicalTrials.gov with MEBSTER as lead sponsor.

NCT NCT06782113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Safety and Efficacy of the UNILEXA Exoskeleton for Regular Verticalization and Assisted Walking
Lead sponsor
MEBSTER
Phase
Observational
Overall status
Active, not recruiting
Start date
November 28, 2024
Completion date
March 31, 2025
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exoskeleton device, spinal cord injury